The development of STING agonists for cancer has been beset by safety issues and discontinued programmes, but Daiichi Sankyo is hoping a new antibody-drug conjugate (ADC) could succeed where others ...

The music box in the hotel lobby is initially locked, but the Ornamental Key is only a few yards away, in the key cubby behind the receptionist's desk in the lobby. Install the Snow White Figurine, ...

Daiichi Sankyo’s Q2 2025 earnings call revealed a significant EPS miss, with actual earnings per share at ¥24.52 versus the forecasted ¥43.89, resulting in a negative surprise of ¥-44.13. Despite a ...

Researchers at Meta FAIR and the University of Edinburgh have developed a new technique that can predict the correctness of a large language model's (LLM) reasoning and even intervene to fix its ...

Thank you for waiting, everybody. We'll now start Daiichi Sankyo's ESMO 2025 Highlights. This is Ken Asakura from Corporate Communications, and I will be the moderator today. First, about the language ...

In recent days, Daiichi Sankyo announced a series of late-breaking clinical trial results at the 2025 European Society for Medical Oncology Congress, highlighting its antibody drug conjugate (ADC) ...

Audiophiles rejoice — later this month, Music Direct is giving away boxes of used records at its warehouse in Chicago's Bowmanville neighborhood. Music Direct announced Thursday that it is closing its ...

Daiichi Sankyo Company (TSE:4568) has been making the rounds among investor circles lately, with some wondering what’s next for this well-known name in pharmaceuticals. Although there haven’t been any ...

LOS ANGELES (KABC) -- The Oscar-winning documentary short, "The Last Repair Shop," tells the story of the devoted people who help keep 80,000 musical instruments working for students in the Los ...

“As bempedoic acid and ezetimibe are already approved as a single-dose therapy, the development of an oral triple combination with different doses of a statin, will make it easier for physicians to ...

(RTTNews) - Japanese healthcare firm Daiichi Sankyo Co., Ltd (DSKYF.PK) reported Thursday first-quarter profit attributable to shareholders of 85.50 billion Japanese yen, up 0.1 percent from 85.38 ...

Daiichi Sankyo reported a strong start to its fiscal year with revenue of JPY 475 billion, or 9% year-on-year growth. Core operating profit was JPY 96 billion, which is 27% progress on its full-year ...